Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Chemical Actions and Uses > Pharmacologic Actions > Physiological Effects of Drugs > Hormones, Hormone Substitutes, and Hormone Antagonists > Hormones > Gastrointestinal Hormones > Proglucagon > Glucagon-Like Peptides > Glucagon-Like Peptide 1 > Liraglutide
... > Amino Acids, Peptides, and Proteins > Proteins > Protein Precursors > Proglucagon > Glucagon-Like Peptides > Glucagon-Like Peptide 1 > Liraglutide
... > Chemical Actions and Uses > Pharmacologic Actions > Physiological Effects of Drugs > Hormones, Hormone Substitutes, and Hormone Antagonists > Hormones > Peptide Hormones > Pancreatic Hormones > Proglucagon > Glucagon-Like Peptides > Glucagon-Like Peptide 1 > Liraglutide
... > Amino Acids, Peptides, and Proteins > Peptides > Peptide Hormones > Pancreatic Hormones > Proglucagon > Glucagon-Like Peptides > Glucagon-Like Peptide 1 > Liraglutide

Preferred term

Liraglutide  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • NN 2211
  • Saxenda
  • Victoza

Scope note

  • An analog of GLUCAGON-LIKE PEPTIDE 1 and agonist of the GLUCAGON-LIKE PEPTIDE 1 RECEPTOR that is used as a HYPOGLYCEMIC AGENT and supplemental therapy in the treatment of DIABETES MELLITUS by patients who do not respond to METFORMIN.

History note

  • 2016 (2001)

In other languages

URI

http://www.yso.fi/onto/mesh/D000069450

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/1/15, last modified 5/31/23